Nordic
For Healthcare professionals
CSL Behring is committed to improving the quality of life for patients with rare and serious diseases. The company develops, manufactures and markets a range of products for the following therapy areas:
Bleeding disorders:
Products for the treatment of Congenital FXIII Deficiency, Congenital Fibrinogen Deficiency, Haemophilia, Rapid Warfarin Reversal and von Willebrand Disease.
Immunology:
Products for the treatment of Immune Deficiency Disorders and Haemolytic Disease of the Newborn
Critical Care:
Products for the treatment of Hypovolaemic Shock, Perioperative Prophylaxis of Bleedings, Hereditary Angioedema and Acute Myocardial Infarction
For Patients
Highlights